Showing 43,261 - 43,280 results of 111,445 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (fold decrease)) ))', query time: 1.24s Refine Results
  1. 43261

    Pharmacokinetics of a Slow-Release Formulation of Soybean Isoflavones in Healthy Postmenopausal Women by Kenneth D. R. Setchell (275564)

    Published 2005
    “…These findings are indicative of a decreased rate of absorption, consistent with the observed slow in vitro dissolution rate. …”
  2. 43262
  3. 43263

    Illustrative summary of major findings. by Mesfin Esayas Lelisho (14790769)

    Published 2023
    “…<div><p>Background</p><p>Insomnia is a prevalent sleep disorder that affects people all over the world. …”
  4. 43264

    The stop signalling strength can be the control parameter in a speed-robustness trade-off. by Andreagiovanni Reina (817716)

    Published 2022
    “…These results are in agreement with field observations that documented an increase in stop signalling when a quick response to environmental changes was necessary [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1010090#pcbi.1010090.ref010" target="_blank">10</a>]. …”
  5. 43265

    A half-century of changes in migratory landbird numbers along coastal Massachusetts by Matthew D. Kamm (7354754)

    Published 2019
    “…Although continent-wide there has been an overall decrease in landbird populations over the past 40 years, we found a variety of patterns in abundance over time. …”
  6. 43266
  7. 43267
  8. 43268

    A 15-gene classifier can predict radiation dose levels in mice. by Joseph Lucas (104191)

    Published 2014
    “…While IGH-6 expression decreased in response to irradiation, LOXL1 expression increased promptly and CDKN1A was a late responsive gene.…”
  9. 43269

    A Hypomorphic Lsd1 Allele Results in Heart Development Defects in Mice by Thomas B. Nicholson (406800)

    Published 2013
    “…While there is evidence that Lsd1-interacting proteins regulate the activity and specificity of Lsd1, the significance and roles of such interactions in developmental processes remain largely unknown. Here we describe a hypomorphic Lsd1 allele that contains two point mutations in the tower domain, resulting in a protein with reduced interaction with known binding partners and decreased enzymatic activity. …”
  10. 43270

    The kinetics of the linear component affect the peak frequency of a bell shaped response. by Patrick A. Fletcher (583336)

    Published 2014
    “…(<b>B</b>) The corresponding bell-shaped responses have a peak that shifts to the right accordingly. (<b>C</b>) Duration compensation: increasing τ<sub>a</sub> shifts the response in </a><a><sub>on,∞</sub> and its K crossing point to the right. …”
  11. 43271
  12. 43272

    Image1_LIT01-196, a Metabolically Stable Apelin-17 Analog, Normalizes Blood Pressure in Hypertensive DOCA-Salt Rats via a NO Synthase-dependent Mechanism.pdf by Adrien Flahault (2602345)

    Published 2021
    “…LIT01-196 behaves as a potent full agonist for the apelin receptor and has an in vivo half-life in the bloodstream of 28 min after intravenous (i.v.) and 156 min after subcutaneous (s.c.) administrations in conscious normotensive rats. …”
  13. 43273

    Image1_LIT01-196, a Metabolically Stable Apelin-17 Analog, Normalizes Blood Pressure in Hypertensive DOCA-Salt Rats via a NO Synthase-dependent Mechanism.pdf by Adrien Flahault (2602345)

    Published 2021
    “…LIT01-196 behaves as a potent full agonist for the apelin receptor and has an in vivo half-life in the bloodstream of 28 min after intravenous (i.v.) and 156 min after subcutaneous (s.c.) administrations in conscious normotensive rats. …”
  14. 43274

    Image2_LIT01-196, a Metabolically Stable Apelin-17 Analog, Normalizes Blood Pressure in Hypertensive DOCA-Salt Rats via a NO Synthase-dependent Mechanism.pdf by Adrien Flahault (2602345)

    Published 2021
    “…LIT01-196 behaves as a potent full agonist for the apelin receptor and has an in vivo half-life in the bloodstream of 28 min after intravenous (i.v.) and 156 min after subcutaneous (s.c.) administrations in conscious normotensive rats. …”
  15. 43275

    Image2_LIT01-196, a Metabolically Stable Apelin-17 Analog, Normalizes Blood Pressure in Hypertensive DOCA-Salt Rats via a NO Synthase-dependent Mechanism.pdf by Adrien Flahault (2602345)

    Published 2021
    “…LIT01-196 behaves as a potent full agonist for the apelin receptor and has an in vivo half-life in the bloodstream of 28 min after intravenous (i.v.) and 156 min after subcutaneous (s.c.) administrations in conscious normotensive rats. …”
  16. 43276
  17. 43277

    DataSheet_1_Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis.pdf by Zaigham Abbas Rizvi (6167057)

    Published 2022
    “…Prophylactic treatment with GG showed protection against loss in body weight and a 35%–40% decrease in lung viral load along with reduced lung pathology in the hamster model. …”
  18. 43278

    Adipose-derived stem cells attenuate pulmonary microvascular hyperpermeability after smoke inhalation by Koji Ihara (4495504)

    Published 2017
    “…Sheep were randomly allocated to two groups: 1) ASCs: infused with 200 million of ASCs in 200mL of PlasmaLyteA starting 1 hours post-injury, n = 5; 2) control, treated with 200mL of PlasmaLyteA in a similar pattern, n = 5.…”
  19. 43279

    Image_2_Identification of Sorafenib as a Treatment for Type 1 Diabetes.tif by Qin Zeng (166641)

    Published 2022
    “…Since sorafenib is classified as an FDA-approved drug, it serves as a preliminary lead point for additional experimentation and may be a promising therapy for type 1 diabetes in humans.…”
  20. 43280

    Illustration of three simple scenarios of association between genotype and a bivariate phenotype. by Matthew Stephens (3815)

    Published 2013
    “…A) A variant associated with <i>weight</i> but not <i>height</i>. …”